PVT1 and non-small cell lung carcinoma: Our results suggest that the PVT1/miR-143–3p/CDK1 axis may be a crucial mechanism whereby PVT1 inhibits miR-143–3p activity, resulting in CDK1 derepression and improved cell cycle progression in NSCLC.